MRE-269

Suppliers

Names

[ CAS No. ]:
475085-57-5

[ Name ]:
MRE-269

[Synonym ]:
Acetic acid, 2-[4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-
MRE-269
2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID
2-(4-{[(3,5-dichlorophenyl)carbamoyl]amino}phenoxy)-2-methylpropanoic acid
{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}acetic acid
{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}acetic acid
4-(3,5-dichlorophenylureido)phenoxyisobutyric acid
{4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}acetic acid
ACT-333679
2-<4<<<(3,5-dichlorophenyl)amino>carbonyl>amino>phenoxy>-2-methylpropionic acid
2-{4-[N'-(3,5-dichlorophenyl)ureido]phenoxy}isobutyric acid
2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid
Propanoic acid,2-[4-[[[(3,5-dichlorophenyl)amino]carbonyl]amino]phenoxy]-2-methyl

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
602.1±55.0 °C at 760 mmHg

[ Molecular Formula ]:
C25H29N3O3

[ Molecular Weight ]:
419.516

[ Flash Point ]:
318.0±31.5 °C

[ Exact Mass ]:
419.220886

[ PSA ]:
75.55000

[ LogP ]:
5.09

[ Vapour Pressure ]:
0.0±1.8 mmHg at 25°C

[ Index of Refraction ]:
1.588

[ Storage condition ]:
2-8℃

Synthetic Route

Precursor & DownStream

Precursor

  • 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butyl ester

DownStream


Related Compounds

  • MRE-269-d7
  • MRE-269-d6
  • MRE 3008F20
  • 5-methyl-7-propyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-3H-[1,2,4]triazolo[1,5-c]pyrimidin-2-one
  • N,N-diethylethanamine,3-[(2Z)-5-methoxy-2-[[1-(3-sulfonatopropyl)-5,9b-dihydrobenzo[e][1,3]benzothiazol-1-ium-2-yl]methylidene]-1,3-benzothiazol-3-yl]propane-1-sulfonate
  • (2Z)-3-ethyl-2-[[(3E)-3-[(E)-3-[(3E)-3-[(3-ethyl-5,6-dimethoxy-1,3-benzothiazol-3-ium-2-yl)methylidene]-5,5-dimethylcyclohexen-1-yl]prop-2-enylidene]-5,5-dimethylcyclohexen-1-yl]methylidene]-5,6-dimethoxy-1,3-benzothiazole,perchlorate
  • 2-Methyl-3-[(3-methylbutan-2-yl)amino]benzoic acid
  • 2-(4-ethyl-2-methyl-6-oxopyrimidin-1(6H)-yl)-N-(4-(trifluoromethyl)phenyl)acetamide
  • 2-(2-methyl-4-oxo-5,6,7,8-tetrahydroquinazolin-3(4H)-yl)-N-(m-tolyl)acetamide
  • N-(butan-2-yl)tricyclo[5.2.1.0,2,6]decan-8-amine
  • N-[2-(Cyclopentylthio)phenyl]-I+/--methyl-3-pyridinemethanamine
  • N-[3-(4-bromo-1H-indol-1-yl)propanoyl]glycine
  • N-(4-methoxyphenyl)-2-(4-oxo-5,6,7,8-tetrahydroquinazolin-3(4H)-yl)acetamide
  • N-(2,4-dimethoxyphenyl)-2-(4-oxo-5,6,7,8-tetrahydroquinazolin-3(4H)-yl)acetamide
  • N-(3,5-dimethoxyphenyl)-2-(4-oxo-3,4,5,6,7,8-hexahydroquinazolin-3-yl)acetamide
  • N-(4-acetylphenyl)-2-(4-oxo-5,6,7,8-tetrahydroquinazolin-3(4H)-yl)acetamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.